AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer Drug

AstraZeneca is aiming to expand its presence in the oncology industry with a new drug rights acquisition. The pharmaceutical company said on Thursday that it’s agreed to pay up to $6.9 billion for a cancer drug developed by Japanese drugmaker Daiichi-Sankyo. The sum includes an upfront payment of $1.4 billion and the possibility of paying […]

Xeralto to Become First Prescription Drug With TV Ads That Includes Pricing

Xeralto has been a popular drug-thinner for years–and the target of more than 25,000 lawsuits recently settled by Bayer AG and Johnson & Johnson for $775 million. Now Xeralto, a brand name for generic rivaroxaban, is getting some attention for something different. It’s about to become the first drug to include prices in television ads, […]

Johnson & Johnson and Bayer Settle Xarelto Lawsuits for $775 Million

Two pharmaceutical giants agreed on Monday to settle more than 25,000 lawsuits in the United States in which plaintiffs alleged injuries and death due to taking prescription blood thinner Xarelto. According to Reuters, drug makers Bayer AG and Johnson & Johnson, the two companies that jointly developed the medication, have agreed to settle with plaintiffs […]

National Portrait Gallery Rejects Donation From Purdue Pharma’s Sackler Family

A British art gallery has decided it won’t take 1 million pound ($1.3 million) pledge from a charitable organization run by Purdue Pharma’s Sackler family. In a statement on Wednesday, the National Portrait Gallery said that “recent reporting of allegations made against Sackler family members may cause this new donation to deflect the National Portrait […]

Fewer People Are Strategizing With Prescription Drug Choices to Control Their Health Care Costs

The U.S. has the highest drug prices in the world. Despite enormous expenses in research and marketing, pharmaceutical companies have the tenth highest profit levels among all industries. Despite some attention from Congress and the administration, prices remain high and promise to continue do so, at least in the immediate future. You might expect that […]

Opioid Prescriptions Are Down—But Patients Are Using Them Longer

Doctors are prescribing fewer opioids, but that doesn’t necessarily mean translate to good news in the fight against opioid addiction. Between 2006 and 2017, 223.7 million opioid prescriptions were filled each year, according to a new study in the Journal of the American Medical Association. Opioid prescription rates annually rose to a peak in 2010, […]

UnitedHealth Expands Drug Rebate Program to Consumers

UnitedHealth, the country’s largest health insurer, said Tuesday it would expand a program that passes drug manufacturer rebates directly to consumers, the Associated Press reported. Starting in 2020, new employer-sponsored health insurance coverage that used UnitedHealthcare and pharmacy benefit manager OptumRx, also a division of UnitedHealth, would have to include point-of-sale pharmacy discounts. The trial […]

U.S. Drug Prices, But Not Out-of-Pocket Costs, Are the World’s Highest

With drug prices rising sitting at 10% of skyrocketing health care costs and pharmaceutical companies socking away big profits, you might assume that the U.S. has the highest prescription drug spending in the world. And you’d be right. Per capita prescription expenses in 2016 were $1,016 in this country, while the comparable country average was […]

Trump Administration Hands Out Record Number of Orphan Drug Approvals

A federal incentive for research into rare diseases for so-called orphan drugs is beloved by pharmaceutical companies. And during Donald Trump’s first two years in office, the Food and Drug Administration has been authorizing them at an unprecedented rate, according to Axios. Rare diseases are those that affect 200,000 or fewer people in the country, […]

Drugmaker Lilly to Launch a Half-Price, Generic Version of Its Top-Selling Insulin

Drugmaker Eli Lilly & Co. will offer a half-priced version of its blockbuster insulin, becoming one of the first companies to effectively cut the price of a top-selling drug amid the ongoing U.S. debate over pharmaceutical costs. While it will continue selling its brand-name version at the existing price, Indianapolis-based Lilly will also sell a […]